Your browser doesn't support javascript.
loading
24-Hour Intraocular Pressure Control with Fixed-dose Combination Brinzolamide 1%/Brimonidine 0.2%: A Multicenter, Randomized Trial.
Weinreb, Robert N; Bacharach, Jason; Fechtner, Robert D; Kahook, Malik Y; Wirta, David; Burmaster, Steve; Meng, Xiangyi; Hubatsch, Douglas A.
Afiliação
  • Weinreb RN; Hamilton Glaucoma Center and Shiley Eye Institute, University of California San Diego, San Diego, California. Electronic address: hiiop@aol.com.
  • Bacharach J; North Bay Eye Associates Inc., Petaluma, California.
  • Fechtner RD; Department of Ophthalmology, SUNY Upstate Medical University, Syracuse, New York.
  • Kahook MY; Department of Ophthalmology, University of Colorado School of Medicine, Aurora, Colorado.
  • Wirta D; Aesthetic Eye Care Institute & Eye Research Foundation, Newport Beach, California.
  • Burmaster S; Novartis Pharmaceuticals Corporation, Fort Worth, Texas.
  • Meng X; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Hubatsch DA; Novartis Pharmaceuticals Corporation, Fort Worth, Texas.
Ophthalmology ; 126(8): 1095-1104, 2019 08.
Article em En | MEDLINE | ID: mdl-30403988

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sulfonamidas / Tiazinas / Glaucoma de Ângulo Aberto / Hipertensão Ocular / Tartarato de Brimonidina / Pressão Intraocular / Anti-Hipertensivos Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ophthalmology Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sulfonamidas / Tiazinas / Glaucoma de Ângulo Aberto / Hipertensão Ocular / Tartarato de Brimonidina / Pressão Intraocular / Anti-Hipertensivos Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ophthalmology Ano de publicação: 2019 Tipo de documento: Article